Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0000950170-25-110287

Director sold 21,000 shares at $9.25 ($194,250)

  • Director acquired 21,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Tan Aik Na · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-15 Exercise or conversion : show line 1 in the form 10b5-1 +21,000 $9.13 $191,730 61,388 D
2025-08-15 Sale : show line 2 in the form 10b5-1 −21,000 $9.25 $194,250 40,388 D
Open-market sales · 21,000 sh · avg $9.25 · $194,250

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-15 Exercise or conversion : show line 3 in the form 10b5-1 Share Option (right to buy) −21,000 0 D
Loading xslF345X05/ownership.xml…